Medical Industrial Equipment Ltd. – Part 11

6. Failure to designate an individual to review for adequacy and approve prior to issuance all documents established to meet the requirements of Part 820 as required by 21 CFR 820.40(a). For example:

a) There is no requirement for documenting the signature of the individual approving the document.

In your firm’s letter of April 6, 2000, they state that by April 28th they will have a system for attaching electronic signatures to all relevant electronic documents. The software for this system will have been validated by that date.

They state that because they have more than three hundred documents in their quality system it will take them some time to complete the process of having signatures and records of changes on all their documents. They state that by June 30th they will have changed all the documents that cover the quality, design, production planning, purchasing, and stores functions and that by July 31st all documents will have been reviewed, and all relevant documents will have an electronic signature and records of changes.

This response is not adequate because your firm has not submitted documentation of the changes or copies of the procedures.

b) Electronic documents are not electronically signed and there is no signed hard copy record.
Your firm’s response is indicated in 6a above. This response is not adequate because your firm has not submitted documentation of the changes or copies of the procedures.

c) The electronic record system lacks computer generated time stamped audit trails. Your firm’s response is indicated in 6a above. This response is not adequate because your firm has not submitted documentation of the changes or copies of the procedures.

7. Failure to control records as required by 21 CFR 820.40(b). For example: Change records do not include a clear description of the change, reason for the change, a full description of the change, the identification of the affected documents and the signature of the individual approving the changes. Change records consist of a hidden text (footnote) on the electronic record identifying the change. The date of the change is the date the revised procedure was released and saved in the approved procedure file.

Your firm’s response is indicated in 6a above. This response is not adequate because your firm has not submitted documentation of the changes or copies of the procedures. …

9. Failure to validate computer software used as part of the quality system for its intended use according to an established protocol as required by 21 CFR 820.70(i). For example: Software such as Excel, Access, and Word used to create and maintain data bases (rejects, complaints, and concessions) and electronic documents, is not validated.

In their response dated April 3, 2000, your firm stated that by May 31st,they will have identified what software is used for data processing, and identified a method or methods for validation and/or verification of the software. Furthermore, they state, they will complete a full and thorough validation of all software that is used for the handling of information or data used in the quality system. This response is not adequate since your firm has not submitted the required validation information.

SoftwareCPR Keywords: Part 11 Electronic Record Electronic Signatures

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.